A citation-based method for searching scientific literature

Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
Times Cited: 300



Karen A Gelmon, Marc Tischkowitz, Helen Mackay, Kenneth Swenerton, AndrĂ© Robidoux, Katia Tonkin, Hal Hirte, David Huntsman, Mark Clemons, Blake Gilks, Rinat Yerushalmi, Euan Macpherson, James Carmichael, Amit Oza. Lancet Oncol 2011
Times Cited: 778




List of shared articles



Times cited

PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data.
Myrto Moutafi, Panagiota Economopoulou, David Rimm, Amanda Psyrri. Oral Oncol 2021
3

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.
Francesco Schettini, Silvia Paola Corona, Fabiola Giudici, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Carlo Azzini,[...]. Front Oncol 2021
1

Determinants of Homologous Recombination Deficiency in Pancreatic Cancer.
Max M Wattenberg, Kim A Reiss. Cancers (Basel) 2021
0


Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.
Xu Liu, Kan Wu, Dan Zheng, Chuanxu Luo, Yu Fan, Xiaorong Zhong, Hong Zheng. Front Oncol 2021
0

Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations.
Jennifer Taylor Veneris, Ursula A Matulonis, Joyce F Liu, Panagiotis A Konstantinopoulos. Gynecol Oncol 2020
23